Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer.
Ecancermedicalscience
; 11: 767, 2017.
Article
in En
| MEDLINE
| ID: mdl-28955403
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Ecancermedicalscience
Year:
2017
Type:
Article
Affiliation country:
Brazil